IRIS

1.1 Articolo in rivista: [27918] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.961 a 7.980 di 27.918
Titolo Data di pubblicazione Autore(i) File
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 1-gen-2025 Perniola, Simone; Alivernini, Stefano; Gremese, Elisa; Landolfi, Gianpiero; Carrara, Greta; Iagnocco, Annamaria; Scirè, Carlo alberto
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients 1-gen-2021 Atzeni, F; Alciati, A; Salaffi, F; Di Carlo, M; Bazzichi, L; Govoni, M; Biasi, G; Di Franco, M; Mozzani, F; Gremese, E; Dagna, L; Batticciotto, A; Fischetti, F; Giacomelli, R; Guiducci, S; Guggino, G; Bentivegna, M; Gerli, R; Salvarani, C; Bajocchi, G; Ghini, M; Iannone, F; Giorgi, V; Farah, S; Bonazza, S; Barbagli, S; Gioia, C; Marino, Ng; Capacci, A; Cavalli, G; Cappelli, A; Carubbi, F; Nacci, F; Riccucci, I; Cutolo, M; Sinigaglia, L; Sarzi-Puttini, P.
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 1-gen-2022 Gremese, E; Tolusso, B; Bruno, D; Alivernini, S; Ferraccioli, G.
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 1-gen-2020 Sebastiani, M; Manfredi, A; Iannone, F; Gremese, E; Bortoluzzi, A; Favalli, E; Bazzani, C; Salaffi, F; Fusaro, E; Foti, R; Giannitti, C; Caporali, R; Cauli, A; Cassone, G; Lopalco, G; Petricca, L; Ferraccioli, G; Lapadula, G
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 1-gen-2012 Canestri, S; Totaro, Michele Ciro; Serone, E; Tolusso, Barbara; Frezza, D; Gremese, Elisa; Ferraccioli, Gianfranco
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 1-gen-2015 Bortoluzzi, A; Scirè, Ca; Bombardieri, S; Caniatti, L; Conti, F; De Vita, S; Doria, A; Ferraccioli, Gianfranco; Gremese, Elisa; Mansutti, E; Mathieu, A; Mosca, M; Padovan, M; Piga, M; Tincani, A; Tola, Mr; Tomietto, P; Valesini, G; Zen, M; Govoni, M.
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 1-gen-2016 Alivernini, Stefano; Kurowska Stolarska, Mariola; Tolusso, Barbara; Benvenuto, Roberta; Elmesmari, Aziza; Canestri, Silvia; Petricca, Luca; Mangoni, Antonella; Fedele, Anna Laura; Di Mario, Clara; Gigante, Maria Rita; Gremese, Elisa; Mcinnes, Iain B.; Ferraccioli, Gianfranco
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 1-gen-2020 Gremese, E.; Ferraccioli, E. S.; Alivernini, S.; Tolusso, B.; Ferraccioli, G.
QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study 1-gen-2020 Erre, Gian Luca; Piras, Alessandra; Piga, Matteo; Fedele, Anna L; Mangoni, Arduino A; Lazzerini, Pietro E; Gremese, Elisa; Mathieu, Alessandro; Ferraccioli, Gianfranco; Passiu, Giuseppe; Saba, Pier S
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial 1-gen-2020 Khanna, D; Lin, Cjf; Furst, De; Goldin, J; Kim, G; Kuwana, M; Allanore, Y; Matucci-Cerinic, M; Distler, O; Shima, Y; van Laar, Jm; Spotswood, H; Gremese, E; Wagner, B; Siegel, J; Jahreis, A; Denton, Cp
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 1-gen-2021 Bruno, D.; Fedele, A. L.; Tolusso, B.; Barini, A.; Petricca, L.; Di Mario, C.; Barini, A.; Mirone, L.; Ferraccioli, G.; Alivernini, S.; Gremese, E.
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 1-gen-2020 Landi, F.; Gremese, E.; Rota, E.; Carfi, A.; Benvenuto, F.; Ciciarello, F.; Lo Monaco, M. R.; Martone, A. M.; Pagano, F.; Paglionico, A.; Petricca, L.; Rocchi, S.; Tritto, M.; Sanguinetti, M.; Bernabei, R.
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA 1-gen-2018 Iannone, F.; Ferraccioli, G.; Sinigaglia, L.; Favalli, E. G.; Sarzi-Puttini, P.; Atzeni, F.; Gorla, R.; Bazzani, C.; Govoni, M.; Farina, I.; Gremese, E.; Carletto, A.; Giollo, A.; Galeazzi, M.; Foti, R.; Bianchino, L.; La Grasta, L.; Lapadula, G.
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors 1-gen-2012 Iannone, F; Gremese, E; Atzeni, F; Biasi, D; Botsios, C; Cipriani, P; Ferri, C; Foschi, V; Galeazzi, M; Gerli, R; Giardina, A; Marchesoni, A; Salaffi, F; Ziglioli, T; Lapadula, G; Gruppo Italiano di Studio sulle Early Arthritides, (GISEA).
Benefit/risk of cyclosporine in rheumatoid arthritis 1-gen-2004 Gremese, E; Ferraccioli, Gf
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 1-gen-2011 Ferraccioli, Gianfranco; Gremese, Elisa
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 1-gen-2013 Ferraccioli, Gianfranco; Alivernini, Stefano; Gremese, Elisa
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 1-gen-2022 Perniola, Simone; Bizzoca, Rita; Fornaro, Marco; Alivernini, Stefano; Gremese, Elisa; Iannone, Florenzo
Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome 1-gen-2009 Pietrapertosa, D; Salaffi, F; Peluso, G; Bosello, Sl; Fedele, Al; Cuoghi, I; Michelutti, A; Gremese, E; Ferraccioli, Gf
Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs 1-gen-2021 Caruso, C.; Colantuono, S.; Tolusso, B.; Di Mario, C.; Pentassuglia, A.; Rumi, G.; Gremese, E.; Romano, A.; Gasbarrini, A.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.961 a 7.980 di 27.918
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista27918
Autore
  • Oyen, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • Repici, Alessandro717
  • DANESE, Silvio643
  • Hassan, Cesare590
  • Indolfi, Ciro471
  • Marcacci, Maurilio467
  • Fasano, Alfonso465
  • Selmi, Carlo Francesco453
Data di pubblicazione
  • In corso di stampa14
  • 2020 - 20269653
  • 2010 - 201911835
  • 2000 - 20094579
  • 1990 - 19991485
  • 1980 - 1989329
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE372
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
  • ANNALS OF ONCOLOGY244
  • CANCERS232
  • PLOS ONE223
  • THE JOURNAL OF NUCLEAR MEDICINE222
  • JOURNAL OF CLINICAL MEDICINE215
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY197
  • ALLERGY180
Keyword
  • Humans2166
  • Female1035
  • Male996
  • Middle Aged767
  • Aged669
  • Adult559
  • COVID-19442
  • Treatment Outcome373
  • Animals329
  • Retrospective Studies264
Lingua
  • eng19972
  • ita459
  • spa14
  • fre11
  • ger8
  • enm4
  • por2
  • chi1
Accesso al fulltext
  • no fulltext25665
  • reserved1362
  • open891